메뉴 건너뛰기




Volumn 56, Issue 2, 2001, Pages 126-128

The Candesartan and Lisinopril Microalbuminuria (CALM) study: Interest of dual blockade of the retin-angiotensin system in hypertensive type 2 diabetic patients with microalbuminuria;L'étude Clinique du Mois L'étude CALM ou intérêt de combiner un inhibiteur de l'enzyme de conversion et un antagoniste du récepteur de type 1 de l'angiotensine II dans le traitement de la néphropathie diab́tique

Author keywords

ACE inhibitor; AT1 receptor blocker; Diabetic nephropathy; Randomized clinical trial

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO; THIAZIDE DIURETIC AGENT;

EID: 0035099155     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (10)
  • 1
    • 0034627208 scopus 로고    scopus 로고
    • Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
    • (2000) BMJ , vol.321 , pp. 1440-1444
    • Mogensen, C.E.1    Neldam, S.2    Tikkanen, I.3
  • 2
    • 0027737576 scopus 로고
    • La néphropathie diabétique: Histoire naturelle et interventions thérapeutiques
    • (1993) Rev Med Liège , vol.48 , pp. 645-658
    • Scheen, A.J.1
  • 3
    • 0033519752 scopus 로고    scopus 로고
    • Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with IDD and microalbuminuria
    • (1999) BMJ , vol.19 , pp. 24-25
    • Mathiesen, E.R.1    Hommer, E.2    Hansen, H.P.3
  • 10
    • 0033828532 scopus 로고    scopus 로고
    • Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
    • (2000) Am Heart J , vol.140 , pp. 361-366
    • Carson, P.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.